Serum acetylcholine-receptor antibodies in myasthenia gravis.
D000818:Animals; D000906:Antibodies; D000941:Antigens; D001665:Binding Sites; D002038:Bungarotoxins / Q000378:metabolism; D002217:Carbachol / Q000494:pharmacology; D003650:Decamethonium Compounds / Q000494:pharmacology; D003864:Depression, Chemical; D005260:Female; D005916:Globulins / Q000378:metabolism; D006680:HLA Antigens; D006801:Humans; D046911:Macromolecular Substances; D008297:Male; D009121:Muscle Denervation; D009157:Myasthenia Gravis / Q000276:immunology*; D004856:Postural Balance; D011863:Radioimmunoassay; D011955:Receptors, Drug / Q000187:drug effects; D014403:Tubocurarine / Q000494:pharmacology
D000906:Antibodies; D000941:Antigens; D002038:Bungarotoxins; D003650:Decamethonium Compounds; D005916:Globulins; D006680:HLA Antigens; D046911:Macromolecular Substances; D011955:Receptors, Drug; D002217:Carbachol; D014403:Tubocurarine